ACADIA PHARMACEUTICALS INC Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Acadia Pharmaceuticals Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Acadia Pharmaceuticals Inc Other Assets, Noncurrent for the quarter ending June 30, 2024 was $476K, a 95.8% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $476K -$10.8M -95.8% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $476K -$12M -96.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $476K -$7.11M -93.7% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $475K -$5.57M -92.1% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $11.3M +$7.46M +194% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $12.4M +$8.1M +187% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $7.59M +$3.59M +89.8% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $6.04M +$3.67M +155% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $3.84M +$1.85M +92.7% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $4.34M +$2.52M +139% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $4M +$2.32M +138% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $2.37M +$828K +53.6% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $1.99M +$261K +15.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.81M +$471K +35.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.68M -$1.18M -41.3% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $1.55M -$762K -33% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $1.73M +$143K +9.01% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.34M -$223K -14.2% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $2.86M +$958K +50.4% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $2.31M +$881K +61.8% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $1.59M -$1.61M -50.3% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $1.57M +$1.24M +385% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $1.9M +$1.55M +436% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $1.43M +$1.06M +286% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $3.19M +$2.67M +512% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $323K -$345K -51.6% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $354K -$431K -54.9% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $369K -$606K -62.2% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $522K -$589K -53% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $668K -$572K -46.1% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $785K +$456K +139% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $975K +$570K +141% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $1.11M +$778K +234% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $1.24M +$962K +346% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $329K +$42K +14.6% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $405K +$227K +128% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $333K +$222K +200% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $278K +$135K +94.4% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $287K +$108K +60.3% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $178K +$58K +48.3% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $111K +$55K +98.2% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $143K Mar 31, 2014 10-Q 2014-05-06
Q4 2013 $179K Dec 31, 2013 10-K 2015-02-26
Q3 2013 $120K +$118K +5900% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 $56K +$49K +700% Jun 30, 2013 10-Q 2013-08-06
Q3 2012 $2K -$76K -97.4% Sep 30, 2012 10-Q 2012-11-05
Q2 2012 $7K -$79K -91.9% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $11K Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $14K -$105K -88.2% Dec 31, 2011 10-K 2013-03-12
Q3 2011 $78K Sep 30, 2011 10-Q 2011-11-09
Q2 2011 $86K Jun 30, 2011 10-Q 2011-08-10
Q4 2010 $119K Dec 31, 2010 10-K 2012-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.